Exclusive

Publication

Byline

Location

Clinical Trial: FABP4 Response After Roux-en-Y Gastric Bypass

U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07774208) titled 'FABP4 Response After Roux-en-Y Gastric Bypass' on Aug. 12. Brief Summary: This retrospecti... Read More


Clinical Trial: Biomarkers of Cervical Spondylotic Myelopathy

U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07772297) titled 'Biomarkers of Cervical Spondylotic Myelopathy' on Aug. 13. Brief Summary: We believe that ... Read More


Clinical Trial: IV Bevacizumab Treatment of Patients With Hereditary Hemorrhagic Telangiectasia (HHT) or Rendu-Osler (RO) Disease: A Retrospective Analysis of French Cohort Data From 2009 to 2024

U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07772050) titled 'IV Bevacizumab Treatment of Patients With Hereditary Hemorrhagic Telangiectasia (HHT) or Re... Read More


Singapore Clinical Trial: ROSETTA Lung-201: A Randomized, Multicenter, Open-label Phase 3 Study of Pumitamig Monotherapy Compared to Durvalumab in Participants with Unresectable Stage III NSCLC Without Progression After Platinum-based Concurrent Chemoradiation Therapy.

Singapore, Aug. 20 -- The Health Sciences Authority received information related to the study titled 'ROSETTA Lung-201: A Randomized, Multicenter, Open-label Phase 3 Study of Pumitamig Monotherapy Com... Read More


Clinical Trial: A Study of the Pharmacokinetics, Biodistribution and Dosimetry of Granzyme-B Targeted [Cu-64]-Labeled PET Radiotracers in Adult Healthy Volunteers

U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07774650) titled 'A Study of the Pharmacokinetics, Biodistribution and Dosimetry of Granzyme-B Targeted [Cu-6... Read More


Singapore Clinical Trial: A Phase 2, Randomized, Open-Label Study of VVD-133214 in Combination with Pembrolizumab compared with Pembrolizumab monotherapy in participants with advanced colorectal adenocarcinoma (CRC) harboring microsatellite instability (MSI) and/or deficient mismatch repair (DMMR)

Singapore, Aug. 20 -- The Health Sciences Authority received information related to the study titled 'A Phase 2, Randomized, Open-Label Study of VVD-133214 in Combination with Pembrolizumab compared w... Read More


Singapore Clinical Trial: A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Investigator Choice of Chemotherapy (modified FOLFIRINOX or Gemcitabine plus Nab-paclitaxel) with or without Zoldonrasib (RMC 9805) as First-line Treatment in Patients with Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma (RASolute 305)

Singapore, Aug. 20 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Investigator Choice of Chemothera... Read More


Clinical Trial: Preoperative Anxiety in Patients Undergoing RIRS and PCNL

U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07772830) titled 'Preoperative Anxiety in Patients Undergoing RIRS and PCNL' on Aug. 14. Brief Summary: This... Read More


Clinical Trial: Platform for End-of-life Awareness, Conversations, and Education (PEACE) Among Registered Nurses

U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07774468) titled 'Platform for End-of-life Awareness, Conversations, and Education (PEACE) Among Registered N... Read More


Singapore Clinical Trial: A Phase 1, Investigator- and Participant-Blinded, Placebo-Controlled, Randomized, Multiple-Dose Study to Evaluate the Gastric Emptying Delay, Pharmacokinetics, Safety, and Tolerability of Eloralintide in Participants with Obesity or Overweight

Singapore, Aug. 20 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Investigator- and Participant-Blinded, Placebo-Controlled, Randomized, Multiple-Dose St... Read More